Browsing Tag
neurological disorders
6 posts
Acadia’s LOTUS study confirms long‑term benefits and manageable side‑effects of DAYBUE over 12 months in Rett syndrome
New real-world data shows DAYBUE improves Rett syndrome symptoms and is tolerable over 12 months. Find out what the LOTUS study reveals for patients and doctors.
Merz Therapeutics acquires INBRIJA and FAMPYRA from Acorda Therapeutics to bolster neurological portfolio
In a strategic move enhancing its presence in the neurology sector, Merz Therapeutics has successfully completed the acquisition…
Quanterix launches diagnostic test aiding early Alzheimer’s detection
Quanterix, a biomarker detection firm powering scientific research and breakthrough diagnostics, has introduced LucentAD, a new test designed…
Sage Therapeutics strikes $3.1bn licensing deal with biogen for depression and neurological disorder treatments
Sage Therapeutics has entered into a high-stakes global collaboration and licensing agreement with Biogen, valued at up to…
Convelo, Genentech to collaborate on remyelination drugs for MS
US biotech company Convelo Therapeutics has signed an exclusive worldwide collaboration with Roche subsidiary Genentech to fast track…
Prevacus partners with Blinktbi for advanced concussion drug trials
Prevacus, a leading US biopharmaceutical company, has announced a strategic partnership with medical device company Blinktbi, utilizing their…